Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Tilray Brands Inc (TLRY) Price & Performance

MicroSectors FANG and Innovation 3X Leveraged ETNTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

MicroSectors FANG and Innovation 3X Leveraged ETN vs Tilray Brands Inc — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $32.54, while Tilray Brands Inc trades at $4.74 (market cap $649.42M). The key difference: MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

FNGUTLRY
Sector
Leveraged / InverseHealth
52-Week High
$36.15$21.00
52-Week Low
$13.73$3.88
Market Cap
$649.42M
Enterprise Value
$816.55M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU, a 3X leveraged ETN tracking the FANG+ Index, trades at $32.53, down 3.47% on the day. Technical indicators show a bullish trend with moving averages supporting upside, though RSI levels suggest overbought conditions. Recent news highlights extreme volatility, with a 16% single-session loss reported on June 5, 2026, underscoring the product's leveraged risk.

The outlook for FNGU hinges on continued strength in mega-cap tech stocks, but risks are elevated due to leverage decay and market volatility. Investors face potential for amplified gains or losses, with sentiment cautious amid recent sharp declines. Careful risk management is essential given the ETN's structure.

Tilray Brands Inc

TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.

Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.

Returns comparison

Trailing returns across standard periods

About MicroSectors FANG and Innovation 3X Leveraged ETN

FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.

Read more on FNGU

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY